DK144093D0 - - Google Patents
Info
- Publication number
- DK144093D0 DK144093D0 DK144093A DK144093A DK144093D0 DK 144093 D0 DK144093 D0 DK 144093D0 DK 144093 A DK144093 A DK 144093A DK 144093 A DK144093 A DK 144093A DK 144093 D0 DK144093 D0 DK 144093D0
- Authority
- DK
- Denmark
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK144093A DK144093D0 (enrdf_load_stackoverflow) | 1993-12-23 | 1993-12-23 | |
AU12725/95A AU1272595A (en) | 1993-12-23 | 1994-12-22 | A method of producing glucagon-like peptide 1 |
PCT/DK1994/000487 WO1995017510A1 (en) | 1993-12-23 | 1994-12-22 | A method of producing glucagon-like peptide 1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK144093A DK144093D0 (enrdf_load_stackoverflow) | 1993-12-23 | 1993-12-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK144093D0 true DK144093D0 (enrdf_load_stackoverflow) | 1993-12-23 |
Family
ID=8104857
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK144093A DK144093D0 (enrdf_load_stackoverflow) | 1993-12-23 | 1993-12-23 |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU1272595A (enrdf_load_stackoverflow) |
DK (1) | DK144093D0 (enrdf_load_stackoverflow) |
WO (1) | WO1995017510A1 (enrdf_load_stackoverflow) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7138486B2 (en) | 1986-05-05 | 2006-11-21 | The General Hospital Corporation | Insulinotropic hormone derivatives and uses thereof |
US5614492A (en) * | 1986-05-05 | 1997-03-25 | The General Hospital Corporation | Insulinotropic hormone GLP-1 (7-36) and uses thereof |
US6849708B1 (en) | 1986-05-05 | 2005-02-01 | The General Hospital Corporation | Insulinotropic hormone and uses thereof |
FR2686899B1 (fr) | 1992-01-31 | 1995-09-01 | Rhone Poulenc Rorer Sa | Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant. |
US6284727B1 (en) | 1993-04-07 | 2001-09-04 | Scios, Inc. | Prolonged delivery of peptides |
CA2264243C (en) * | 1996-08-30 | 2004-10-05 | Novo Nordisk A/S | Glp-1 derivatives |
US6461834B1 (en) | 1998-11-06 | 2002-10-08 | Bionebraska, Inc. | Clostripain catalyzed amidation of peptides |
EP2067488A1 (en) | 2000-04-12 | 2009-06-10 | Human Genome Sciences, Inc. | Albumin fusion proteins |
CN1162446C (zh) * | 2001-05-10 | 2004-08-18 | 上海华谊生物技术有限公司 | 促胰岛素分泌肽衍生物 |
CN1363654A (zh) | 2001-07-19 | 2002-08-14 | 上海华谊生物技术有限公司 | 生产促胰岛素分泌肽glp-1(7-36)的基因工程菌以及生产glp-1(7-36)的方法 |
WO2005003296A2 (en) | 2003-01-22 | 2005-01-13 | Human Genome Sciences, Inc. | Albumin fusion proteins |
EP2990417A1 (en) | 2001-12-21 | 2016-03-02 | Human Genome Sciences, Inc. | Albumin insulin fusion protein |
EP1572720A4 (en) * | 2002-05-24 | 2008-12-24 | Nps Allelix Corp | PROCESS FOR THE ENZYMATIC PRODUCTION OF GLP-2 (1-34) AND GLP-2 (1-33) PEPTIDES |
CA2485701A1 (en) * | 2002-05-24 | 2003-12-04 | Fred W. Wagner | Method for enzymatic production of glp-1 (7-36) amide peptides |
AU2003239865A1 (en) * | 2002-05-24 | 2003-12-12 | Restoragen Inc. | Method for universal enzymatic production of bioactive peptides |
WO2005067368A2 (en) | 2003-11-21 | 2005-07-28 | Nps Allelix Corp. | Production of glucagon like peptide 2 and analogs |
JP5010923B2 (ja) | 2004-02-09 | 2012-08-29 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | アルブミン融合蛋白質 |
CN100429227C (zh) | 2005-06-29 | 2008-10-29 | 常州制药厂有限公司 | Exendin4多肽片段 |
EP1816201A1 (en) | 2006-02-06 | 2007-08-08 | CSL Behring GmbH | Modified coagulation factor VIIa with extended half-life |
WO2016210384A2 (en) | 2015-06-25 | 2016-12-29 | Synlogic, Inc. | Bacteria engineered to treat metabolic diseases |
WO2017139708A1 (en) | 2016-02-10 | 2017-08-17 | Synlogic, Inc. | Bacteria engineered to treat nonalcoholic steatohepatitis (nash) |
JP2020513834A (ja) | 2017-03-20 | 2020-05-21 | ルピン・リミテッド | ペプチドの発現および大規模生産 |
CN113846124A (zh) * | 2021-09-26 | 2021-12-28 | 康霖生物科技(杭州)有限公司 | 一种用于糖代谢相关疾病基因治疗的核酸构建体 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK27885A (da) * | 1985-01-22 | 1986-07-23 | Novo Industri As | Fremstilling af peptider |
US5118666A (en) * | 1986-05-05 | 1992-06-02 | The General Hospital Corporation | Insulinotropic hormone |
US5120712A (en) * | 1986-05-05 | 1992-06-09 | The General Hospital Corporation | Insulinotropic hormone |
EP0428615A4 (en) * | 1988-08-11 | 1991-11-13 | California Biotechnology, Inc. | Method for stabilizing heterologous protein expression and vectors for use therein |
ES2113879T3 (es) * | 1990-01-24 | 1998-05-16 | Douglas I Buckley | Analogos de glp-1 utiles para el tratamiento de diabetes. |
US5202239A (en) * | 1990-08-07 | 1993-04-13 | Scios Nova Inc. | Expression of recombinant polypeptides with improved purification |
-
1993
- 1993-12-23 DK DK144093A patent/DK144093D0/da not_active Application Discontinuation
-
1994
- 1994-12-22 AU AU12725/95A patent/AU1272595A/en not_active Abandoned
- 1994-12-22 WO PCT/DK1994/000487 patent/WO1995017510A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO1995017510A1 (en) | 1995-06-29 |
AU1272595A (en) | 1995-07-10 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A0 | Application filed | ||
ATS | Application withdrawn |